Clinical Trials

Linking Laboratory Findings With Clinical Trials

Benaroya Research Institute at Virginia Mason (BRI) is dedicated to exploring the causes and cures of human disease. Key to this mission is innovation in clinical research. We are committed to staying at the forefront of our changing medical and scientific environments by combining expertise in laboratory investigation with breakthrough research. This bench-to-bedside approach allows for rapid development of scientific findings into medical treatment advancements with the potential to directly benefit people living with disease.

At any given time, BRI has hundreds of clinical trials underway in various phases. BRI's clinical research programs not only develop laboratory discoveries into clinical trials, but also collaborate in studies with pharmaceutical and biotechnology companies, as well as national and federal organizations.

For Clinical Investigators

Research Studies

Explore our research studies underway to get general information about research projects at BRI, or to find out about opportunities to participate in a clinical research study.

Diabetes Clinical Research Program

The Diabetes Clinical Research Program at Benaroya Research Institute is an international leader in Type 1 (autoimmune) diabetes research. The program's goal is to help families with Type 1 diabetes by investigating ways to prevent diabetes, finding new approaches of diagnosing the disease in its earliest stage to optimize the potential for successful treatment, and testing innovative new therapies. Learn about our Diabetes Clinical Research Trials.

Alaska Clinical Trials

The Rasmuson Foundation and the Benaroya Research Institute at Virginia Mason have joined together to enhance medical research opportunities for Alaska residents. To date, Alaskans have had limited access to cutting-edge medical research. Recently, the Benaroya Research Institute at Virginia Mason received a grant from the Rasmuson Foundation that will provide funds for Alaskan residents to travel to Seattle so they can participate in clinical research trials, making the latest therapeutic options available to them. This work will supplement the good work of the individual providers and agencies already serving patients in Alaska.

Frequently Asked Questions (FAQ's)

For more information about clinical research and specific diseases, see frequently asked questions, and other online resources.